Cargando…

The clinical activity of cyproterone acetate in advanced ovarian carcinoma. A London Gynaecology Oncology Group Study.

Detalles Bibliográficos
Autores principales:	Thompson, P., Wilson, P., Osborne, R., Slevin, M., Wiltshaw, F., Blake, P., Harper, P., Coleman, R., Williams, C., Sweetenham, J.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1991
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977484/ https://www.ncbi.nlm.nih.gov/pubmed/1834157

Ejemplares similares

A randomised study of carboplatin vs sequential ifosfamide/carboplatin for patients with FIGO stage III epithelial ovarian carcinoma. The London Gynaecologic Oncology Group.
por: Perren, T. J., et al.
Publicado: (1993)

Single-agent paclitaxel in patients with previously untreated stage IV epithelial ovarian cancer. London Gynaecological Oncology and North Thames Gynaecological Oncology Groups.
por: Gore, M. E., et al.
Publicado: (1997)

A prospective randomised controlled trial of tamoxifen and cyproterone acetate in pancreatic carcinoma.
por: Keating, J. J., et al.
Publicado: (1989)

Voltammetric Determination of Cyproterone Acetate in Pharmaceutical Preparations
por: El-Enany, Nahed, et al.
Publicado: (2010)

Cyproterone acetate acts as a disruptor of the aryl hydrocarbon receptor
por: Chen, Chih-Shou, et al.
Publicado: (2021)

Gynaecological Oncology
por: Osborne, R.J.
Publicado: (1993)

Unilateral proptosis and blindness caused by meningioma in a patient treated with cyproterone acetate
por: Sys, Celine, et al.
Publicado: (2015)

Chronic thromboembolic pulmonary hypertension complicating long-term cyproterone acetate therapy
por: Montani, David, et al.
Publicado: (2014)

SAT397 A Low Dose Cyproterone Acetate In Feminizing Hormone Treatment
por: Korpaisarn, Sira, et al.
Publicado: (2023)

Cyproterone Acetate Mediates IRE1α Signaling Pathway to Alleviate Pyroptosis of Ovarian Granulosa Cells Induced by Hyperandrogen
por: Zhang, Yan, et al.
Publicado: (2022)

Cyproterone acetate or spironolactone in lowering testosterone concentrations for transgender individuals receiving oestradiol therapy
por: Angus, Lachlan, et al.
Publicado: (2019)

A systematic review and meta-analysis of the association between cyproterone acetate and intracranial meningiomas
por: Lee, Keng Siang, et al.
Publicado: (2022)

SUN-042 Low Dose Cyproterone Acetate for the Treatment of Transgender Women - a Retrospective Study
por: Even-Zohar, Naomi, et al.
Publicado: (2020)

Regression of Giant Olfactory Groove Meningioma and Complete Visual Acuity Recovery after Discontinuation of Cyproterone Acetate
por: Bernat, Anne Laure, et al.
Publicado: (2018)

Histomolecular characterization of intracranial meningiomas developed in patients exposed to high-dose cyproterone acetate: an antiandrogen treatment
por: Portet, Sylvain, et al.
Publicado: (2019)

Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women: Results From the ENIGI Study
por: Kuijpers, Suzanne M E, et al.
Publicado: (2021)

Double-Blind, Placebo-Controlled Trial of Cyproterone Acetate to Prevent Flare-Up Effect on Dogs Implanted With Deslorelin
por: Masson, Sylvia, et al.
Publicado: (2021)

Gynaecological Oncology
por: Tindall, V. R.
Publicado: (1976)

Flutamide versus a cyproterone acetate-ethinyl estradiol combination in moderate acne: a pilot randomized clinical trial
por: Adalatkhah, Hassan, et al.
Publicado: (2011)

Evaluation of Risk-Minimization Activities for Cyproterone Acetate 2 mg/Ethinylestradiol 35 µg: A Cross-Sectional Physician Survey
por: Davis, Kimberly H., et al.
Publicado: (2017)

The use of cyproterone acetate in a forensic psychiatric cohort of male sex offenders and its associations with sexual activity and sexual functioning
por: Lippi, Gian, et al.
Publicado: (2017)

Women consuming oral contraceptives containing cyproterone acetate and ethinylestradiol show a higher risk of thyroid cancer than nonusers
por: Lai, Pei-Hsuan, et al.
Publicado: (2023)

Manual of Gynaecologic Oncology
por: Hunter, R.
Publicado: (1981)

Clinical Gynaecologic Oncology
por: Hunter, R.
Publicado: (1981)

Cyproterone acetate enhances TRAIL-induced androgen-independent prostate cancer cell apoptosis via up-regulation of death receptor 5
por: Chen, Linjie, et al.
Publicado: (2017)

Using cyproterone acetate to treat recurrent ischemic priapism in a patient with sickle cell anemia as a comorbidity: a case report
por: Alshahrani, Ali
Publicado: (2020)

Effect of phlebotomy versus oral contraceptives containing cyproterone acetate on the clinical and biochemical parameters in women with polycystic ovary syndrome: a randomized controlled trial
por: Behboudi-Gandevani, Samira, et al.
Publicado: (2019)

Gynaecologic Oncology Controversies in Cancer Treatment
por: Hunter, R.
Publicado: (1982)

Improving attendance to genetic counselling services for gynaecological oncology patients
por: Pokharel, Hanoon P., et al.
Publicado: (2018)

Predictors of complications in gynaecological oncological surgery: a prospective multicentre study (UKGOSOC—UK gynaecological oncology surgical outcomes and complications)
por: Iyer, R, et al.
Publicado: (2015)

Comparison of Drospirenone- with Cyproterone Acetate-Containing Oral Contraceptives, Combined with Metformin and Lifestyle Modifications in Women with Polycystic Ovary Syndrome and Metabolic Disorders: A Prospective Randomized Control Trial
por: Wang, Qiu-Yi, et al.
Publicado: (2016)

No effects of the antiandrogens cyproterone acetate (CPA), flutamide and p,p’-DDE on early sexual differentiation but CPA-induced retardation of embryonic development in the domestic fowl (Gallus gallus domesticus)
por: Jessl, Luzie, et al.
Publicado: (2023)

The comparison of the effectiveness and safety of drospirone ethinyl estradiol and ethinyl estradiol cyproterone in the treatment of polycystic ovarian syndrome: A protocol for systematic review and meta-analysis
por: Liu, Zhimin, et al.
Publicado: (2020)

Primary ovarian Burkitt’s lymphoma: a rare oncological problem in gynaecology: a review of literature
por: Stepniak, Anna, et al.
Publicado: (2017)

Characterization of Atrazine-Induced Gonadal Malformations in African Clawed Frogs (Xenopus laevis) and Comparisons with Effects of an Androgen Antagonist (Cyproterone Acetate) and Exogenous Estrogen (17β-Estradiol): Support for the Demasculinization/Feminization Hypothesis
por: Hayes, Tyrone B., et al.
Publicado: (2006)

Fast-Track Surgery in Gynaecology and Gynaecologic Oncology: A Review of a Rolling Clinical Audit
por: Carter, Jonathan
Publicado: (2012)

Maintenance treatment with interferon for advanced ovarian cancer: results of the Northern and Yorkshire gynaecology group randomised phase III study
por: Hall, G D, et al.
Publicado: (2004)

Tamoxifen in refractory ovarian cancer: the use of a loading dose schedule.
por: Osborne, R. J., et al.
Publicado: (1988)

The clinical correlates of serum CA125 in 169 patients with epithelial ovarian carcinoma.
por: Hawkins, R. E., et al.
Publicado: (1989)

SAT409 Sublingual Estradiol Only, Compared To Combined Oral Estradiol And Cyproterone Acetate,Offers No Apparent Advantage For Gender Affirming Hormone Therapy (GHAT), In Treatment Naïve Transwomen: Results Of A Prospective Pilot Study
por: Yaish, Iris, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e4ia81kmc879919k1mlj277am3